4 models fit Dillard's Inc. Common Stock and they disagree: 0 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver67
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionDillard's Inc. Common Stock (DDS)
Fair value (4 models)
$469
ACCE price target
$544
Rating
Overvalued
Horizon
12 months
Fair value published on 21 Oct 2026, 13:04 CEST; previously $479 since 17 Oct 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Rating published on 21 Oct 2026, 13:04 CEST.
Price used: $696 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
48.3% above
-32.6% to fair value
ACCE score
66
out of 100
Analysts
0% buy
3 covering
P/E
15.9x
forward 20.2x
1-year return
+15.6%
Dividend yield
0.17%
Dillard's Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Dillard's runs roughly 280 department stores across the US under its own nameplate, selling apparel, cosmetics, and home goods, with a sizable credit card operation that helps lock in repeat shoppers. Its moat is mostly a niche one: few mall-based competitors have kept a scaled, profitable footprint in mid-tier and rural markets, and a 40.6% gross margin is healthy for a store-based retailer. The problem is top-line momentum, since revenue is shrinking at 0.4% a year, so any thesis has to rest on margin discipline and capital returns rather than growth. The shares trade on 15.0 trailing earnings but 35.2 forward, which implies the market expects earnings to fall sharply, so the next few quarterly reports on comparable sales and operating margin (currently 5.7%) are the catalyst to watch. With a 33.8% return on equity and a $10.5 billion market cap, the company is worth a closer look mainly to test whether its cash generation holds up through a flat sales environment.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Revenue shrinking despite earnings jump
Revenue fell 0.4% YoY while earnings rose 34.1%, so the profit gain rests on margins rather than sales. Operating margin of 5.7% leaves little room if sales keep slipping.
high
Heavy short interest
Short interest stands at 28.6% of ownership, a large bearish bet that signals the market doubts the earnings growth is durable.
moderate
Price well above model fair value
The stock trades 48.3% above the model fair value of $469.15 and 27.9% above the ACCE price target of $544.00, so the valuation already assumes a lot.
AI research notes
AI-assisted·How I use AIWritten Oct 24, 2026 · figures from 2026-07-31 · prices to Oct 23, 2026
Why it could do well
Free cash flow over the last twelve months reached $624M, a strong cash base for a company with modest debt.
Return on equity of 33.8% and return on invested capital of 20.0% show the business earns high returns on the money invested in it.
Latest quarterly earnings per share came in 54.7% above what analysts expected, showing profits can beat low expectations.
Why it could disappoint
Revenue fell 0.4% year over year, a sharp break from its 8.2% average annual growth over the past five years.
The shares trade 48.3% above the model fair value of $469.15, and all four valuation models sit below the price.
None of the three analysts covering the stock rates it Buy or Strong Buy, and their mean target sits 21.6% below the share price.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 12, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where DDS's valuation models land
Price
$695.68
Model fair value
$469
Model range
$308 to $593
Fair value $469
Price $696
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores